Why Diversified Healthcare Trust Stock Is Back in Focus After Q1 Earnings

Diversified Healthcare Trust (DHC) is drawing fresh attention after first quarter 2026 results showed lower sales and revenue alongside a wider net loss, while external manager The RMR Group pointed to stronger operating trends at the REIT.

At a share price of $8.09, DHC has seen strong recent momentum, with a 30 day share price return of 16.57% and a year to date share price return of 62.45%. The 1 year total shareholder return of 175.60% and very large 3 year total shareholder return suggest earlier investors have already experienced substantial swings in value as sentiment around its healthcare portfolio and earnings outlook has shifted.

If DHC’s rebound has your attention, it can be helpful to see what else is moving in healthcare real estate and services, including companies exposed to digital and AI trends, via 35 healthcare AI stocks

With DHC trading close to analyst targets yet still flagged with an intrinsic discount, the key question is whether recent momentum already reflects the operating progress or if the current price leaves room for further upside.

Most Popular Narrative: 11.6% Overvalued

Compared with the last close at $8.09, the most followed narrative points to a fair value of $7.25. This frames DHC as modestly above that mark while still leaning on detailed cash flow and margin assumptions.

The combination of revised discount rates, revenue and margin assumptions, and peer comparisons is being used to frame a case for a higher long term valuation range.

Curious what sits behind that higher value range? The narrative leans on specific revenue trends, margin repair and a future earnings multiple that might surprise you.

Result: Fair Value of $7.25 (OVERVALUED)

However, you still need to weigh risks, such as high leverage at 8.7x net debt to EBITDAre and refinancing exposure that could pressure margins if conditions tighten.

Another Way To Look At The Valuation

The earlier fair value of $7.25 points to DHC looking 11.6% overvalued, but the P/S ratio tells a different story. At 1.3x, it sits well below the North American Health Care REITs average of 5.8x and close to the 1.4x fair ratio, which hints at a possible valuation cushion rather than excess. Which signal do you trust more when sentiment turns?

For a closer look at how this price compares with peers and where the ratio could shift over time, check out the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed signals on value and sentiment, do you feel the clock ticking to make up your own mind while others react to headlines and short term moves? Use the full picture of risks and potential upsides to pressure test your view with the 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If DHC has you thinking more broadly about where to put fresh capital to work, do not stop here. Widen your search before the next move passes you by.

• Scan for potential value opportunities by using the 51 high quality undervalued stocks that highlight companies combining quality fundamentals with prices that may sit below intrinsic worth.
• Build a watchlist of resilient cash generators by checking the 12 dividend fortresses that focus on companies offering yields of 5% or more.
• Zero in on financial resilience with the solid balance sheet and fundamentals stocks screener (44 results) aimed at companies that pair sturdier balance sheets with underlying business strength.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.